Universe Pharmaceuticals INC Profit Margin

Universe Pharmaceuticals INC (UPC) currently reports a profit margin of -2.3% as of March 2026. That compares with -48.64% in the prior-year period — up 95.3% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Universe Pharmaceuticals INC's profit margin history and peer comparisons.

Universe Pharmaceuticals INC's profit margin increased from -48.64% to -2.3% — a 95.3% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Universe Pharmaceuticals INC's profit margin of -2.3% is lower than the Healthcare sector average of 13.89%. That is roughly 116.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Universe Pharmaceuticals INC's current -2.3% should be judged against Healthcare norms (sector average: 13.89%) and against UPC's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -2.3%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Universe Pharmaceuticals INC, and consider following UPC for alerts when major investors trade the stock.